Functional Analysis of Apoptosis Regulatory Factor GRIM19 in Oral Carcinoma Cells
Project/Area Number |
25462929
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Pathobiological dentistry/Dental radiology
|
Research Institution | Meikai University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
Yoshihiro Ohmori 明海大学, 歯学部, 教授 (50194311)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | GRIM19 / 扁平上皮癌 / アポトーシス / IFN / オートファジー / STAT3 / GRIM-19 / IFN / Lactacystin / rapamycin |
Outline of Final Research Achievements |
We have investigated the expression of the GRIM-19 in oral squamous cell carcinoma cell lines and found a low-GRIM-19 expression cell line (HSC-2) and a high- GRIM-19 expression cell line (Ca9-22). Our results also suggested that the expression of the GRIM-19 is regulated at the protein levels but not transcriptional level. To determine the regulatory mechanism for the expression of GRIM-19 protein, we analyzed the involvement of ubiquitin-proteasome systems and autophagy system using various inhibitors. The results demonstrated that the expression of GRIM-19 protein unregulated by treatment with the proteasome and the autophagy inhibitors in Ca9-22 cells. However neither the proteasome inhibitor nor the autophagy inhibitor enhanced the expression in HSC-2 cells. These results suggest a possibility that the impaired expression of GRIM-19 in HSC-2 cells is due to a mutation in the cording region of the GRIM-19 gene.
|
Report
(4 results)
Research Products
(3 results)